SavedAdd your journal

Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2016 / Cilt: 26 - Sayı: 3

Bladder cancer and relationship of cancer stem cell with recurrence

Mesane kanseri ve kanser kök hücresinin rekürrens ile ilişkisi

Yegane ÇAĞLAR
Fulya ALTUN
ZEKİYE SULTAN ALTUN
SAFİYE AKTAŞ
Pages
185–190
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we aimed to inquire whether bladder cancer and BCG immunotherapy to be applied are effective on cancer stem cells, and discuss underlying mechanisms of frequent recurrences.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this review, we aimed to inquire whether bladder cancer and BCG immunotherapy to be applied are effective on cancer stem cells, and discuss underlying mechanisms of frequent recurrences.
📊
Key Findings & Data:In this review, we aimed to inquire whether bladder cancer and BCG immunotherapy to be applied are effective on cancer stem cells, and discuss underlying mechanisms of frequent recurrences.
💡
Conclusion & Impact:In this review, we aimed to inquire whether bladder cancer and BCG immunotherapy to be applied are effective on cancer stem cells, and discuss underlying mechanisms of frequent recurrences.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this review, we aimed to inquire whether bladder cancer and BCG immunotherapy to be applied are effective on cancer stem cells, and discuss underlying mechanisms of frequent recurrences.

Özet

Bu derleme ile mesane kanseri ve uygulanan BCG immunoterapisinin kanser kök hücrelerinin üzerinde etkin olup olmayacağı sorgulanarak sık rekürrenslerin altında hangi mekanizmaların olabileceğinin tartışılması hedeflenmiştir.

🔖

Cite This Article

ÇAĞLAR, Y., ALTUN, F., ALTUN, Z. S., AKTAŞ, S. (2016). Bladder cancer and relationship of cancer stem cell with recurrence. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 26 - Sayı: 3, 185–190. https://ajindex.com/articles/209865

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Volanis D, Kadiyska T, Galanis A, Delakas D, Logotheti S, Zoumpourlis V. Environmental factors and genetic suscepti- bility promote urinary bladder cancer. Toxicology Let 2010;193:131-137. http://dx.doi.org/10.1016/j.toxlet.2009.12.018
  2. Hodges KB, Beltran AL, Davidson DD, Montironi R, Cheng L. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. Human Path 2010;41:155-162. http://dx.doi.org/10.1016/j.humpath.2009.07.002 Malats n. Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression. Scand J Urol Neph Rol 2008;42:131-140. http://dx.doi.org/10.1080/03008880802285172
  3. Dillioğlugil Ö, Çevik İ. Mesane kanserlerinde etiyoloji, epi- demiyoloji ve risk faktörleri. Özen H, Türkeri L (eds). Üroonkoloji. 1. baskı, Ertem Basım, Ankara, 2007. s.151- 257. Kamat AM, Karam JA, Grossman HB, Kader AK, Munsell M, Dinney CP. Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximi- zing sensitivity. BJU Int 2011;22:15. http://dx.doi.org/10.1111/j.1464-410x.2010.10026.x
  4. Stenzl A, Witjes JA, Cowan NC, Santis MD, Kuczyk M, Lebret T, et al. Bladder cancer muscle invasive and metasta- tic: European Association of Urology Guidelines 2011; 59:1009-1018. http://dx.doi.org/10.1016/j.eururo.2011.03.023 Messing EM. Üriner traktın ürotelyal tümörleri. Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds). Campbell Urology. 8. Baskı. 4. Cilt, Güneş Kitabevi, Ankara, 2005. s.2732-2765. Skinner DG. Cancer of the bladder. Gillenwater JY, Grayhack JT, Howards SS, Mitchell ME (Eds.). Adult and pediatric urology. 4th ed. Lippincott Williams & Wilkıns, Philadelphia; 2002. p.1297-1363
  5. Atakan İH, Kaya E, Kaplan M, Alagöl B, İnci O. Yüzeyel mesane tümörlerinde intrakaviter BCG uygulaması. Türk Üroloji Dergisi 1999;25:123-126.
  6. Soloway MS, Sofer M, Vaidya A. Contemporary manage- ment of stage T1 transitional cell carcinoma of the bladder. J Urol 2002;167:1573-83. http://dx.doi.org/10.1016/S0022-5347(05)65157-9 İnci O. Ürogenital tümörler, 3. baskı, Nobel Tıp, İstanbul, 1995. s.51-105.
  7. Bohle A, Brandau S. Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder can- cer. J Urol 2003;170:964-969. http://dx.doi.org/10.1097/01.ju.0000073852.24341.4a
  8. Kurth K, Tunn U, Ay R, Schröder FH, Pavone-Macaluso M, Debruyne F, et al. Adjuvant chemotherapy for superficial transitional cell bladder carcinoma